Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
SymbolNYSE:ANTM
CUSIP94973V10
Phone800-331-1476
Debt
Debt-to-Equity Ratio0.67
Current Ratio1.49
Quick Ratio1.49
Price-To-Earnings
Trailing P/E Ratio20.33
Forward P/E Ratio15.91
P/E Growth1.35
Sales & Book Value
Annual Sales$90.04 billion
Price / Sales0.69
Cash Flow$16.1384 per share
Price / Cash15.17
Book Value$103.22 per share
Price / Book2.37
Profitability
EPS (Most Recent Fiscal Year)$12.04
Net Income$3.84 billion
Net Margins4.60%
Return on Equity12.77%
Return on Assets4.82%
Miscellaneous
Employees56,000
Outstanding Shares255,200,000
Anthem (NYSE:ANTM) Frequently Asked Questions
What is Anthem's stock symbol?
Anthem trades on the New York Stock Exchange (NYSE) under the ticker symbol "ANTM."
How often does Anthem pay dividends? What is the dividend yield for Anthem?
Anthem announced a quarterly dividend on Thursday, April 26th. Stockholders of record on Friday, June 8th will be paid a dividend of $0.75 per share on Monday, June 25th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date is Thursday, June 7th. View Anthem's Dividend History.
How will Anthem's stock buyback program work?
Anthem declared that its board has initiated a share repurchase program on Friday, December 8th 2017, which permits the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback programs are often an indication that the company's board believes its stock is undervalued.
How were Anthem's earnings last quarter?
Anthem Inc (NYSE:ANTM) issued its earnings results on Wednesday, April, 25th. The company reported $5.41 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $4.83 by $0.58. The company had revenue of $22.34 billion for the quarter, compared to analysts' expectations of $22.55 billion. Anthem had a return on equity of 12.77% and a net margin of 4.60%. The company's revenue for the quarter was up .1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $4.68 earnings per share. View Anthem's Earnings History.
When is Anthem's next earnings date?
What guidance has Anthem issued on next quarter's earnings?
Anthem updated its FY18 earnings guidance on Wednesday, April, 25th. The company provided EPS guidance of more than $15.30 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $15.13.
What price target have analysts set for ANTM?
18 brokerages have issued 12-month target prices for Anthem's stock. Their predictions range from $151.00 to $332.00. On average, they expect Anthem's stock price to reach $248.7692 in the next twelve months. View Analyst Ratings for Anthem.
What are Wall Street analysts saying about Anthem stock?
Here are some recent quotes from research analysts about Anthem stock:
- 1. According to Zacks Investment Research, "Anthem's prudent acquisitions, improving net investment income, divestitures and ACO arrangements pave the way for long-term growth of the company. Its diverse product portfolio has also helped improving its underwriting results. Following the acquisition of America's 1st Choice and HealthSun Anthem, Anthem emerged as the third largest Medicare Advantage plan in the fast-growing Florida market. The company’s solid medical membership should boost its revenues. Its strong capital position backs effective capital deployment via share buybacks and regular dividends. The company’s shares have witnessed its 2018 and 2019 earnings estimates move upward. However, reduction in individual membership from exits in the ACA-compliant marketplace dragged the top line. Shares of the company have underperformed the growth of its industry in the past year. Loss incurred on public exchange business and rising debt continue to bother." (6/20/2018)
- 2. Cantor Fitzgerald analysts commented, "This morning, ANTM reported 1Q18 results; Revenue was slightly below our estimate while adjusted EPS was well ahead of our forecast." (4/25/2018)
Are investors shorting Anthem?
Anthem saw a decline in short interest during the month of May. As of May 15th, there was short interest totalling 3,818,577 shares, a decline of 44.5% from the April 30th total of 6,879,211 shares. Based on an average trading volume of 1,459,282 shares, the short-interest ratio is presently 2.6 days. Currently, 1.5% of the shares of the stock are short sold. View Anthem's Current Options Chain.
Who are some of Anthem's key competitors?
Who are Anthem's key executives?
Anthem's management team includes the folowing people:
- Ms. Gail Koziara Boudreaux, Pres, CEO & Director (Age 57)
- Mr. John Edward Gallina, Exec. VP & CFO (Age 58)
- Ms. Gloria Marie McCarthy, Exec. VP and Chief Admin. & Transformation Officer (Age 65)
- Mr. Peter David Haytaian, Exec. VP & Pres of Commercial and Specialty Bus. Division (Age 48)
- Mr. Ronald William Penczek, Sr. VP & Chief Accounting Officer (Age 53)
Has Anthem been receiving favorable news coverage?
Press coverage about ANTM stock has been trending somewhat positive on Saturday, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Anthem earned a news impact score of 0.02 on Accern's scale. They also assigned media headlines about the company an impact score of 47.61 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.
Who are Anthem's major shareholders?
Anthem's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.85%), Baillie Gifford & Co. (1.90%), Northern Trust Corp (1.23%), Dimensional Fund Advisors LP (1.17%), First Eagle Investment Management LLC (1.16%) and Boston Partners (1.15%). Company insiders that own Anthem stock include Brian T Griffin, Gloria M Mccarthy, John E Gallina, Jose D Tomas, Joseph Swedish, Julie A Hill, Ramiro G Peru, Robert L Dixon Jr, Ronald W Penczek, Thomas C Zielinski and William J Ryan. View Institutional Ownership Trends for Anthem.
Which institutional investors are selling Anthem stock?
ANTM stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., LSV Asset Management, Boston Partners, Wells Fargo & Company MN, FIL Ltd, Millennium Management LLC, Sei Investments Co. and First Eagle Investment Management LLC. Company insiders that have sold Anthem company stock in the last year include Brian T Griffin, Gloria M Mccarthy, John E Gallina, Joseph Swedish, Julie A Hill, Robert L Dixon Jr, Ronald W Penczek and Thomas C Zielinski. View Insider Buying and Selling for Anthem.
Which institutional investors are buying Anthem stock?
ANTM stock was bought by a variety of institutional investors in the last quarter, including CI Global Investments Inc., BlackRock Inc., Allianz Asset Management GmbH, Artisan Partners Limited Partnership, Summit Trail Advisors LLC, MUFG Securities EMEA plc, Eaton Vance Management and CI Investments Inc.. View Insider Buying and Selling for Anthem.
How do I buy shares of Anthem?
Shares of ANTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Anthem's stock price today?
One share of ANTM stock can currently be purchased for approximately $244.82.
How big of a company is Anthem?
Anthem has a market capitalization of $62.03 billion and generates $90.04 billion in revenue each year. The company earns $3.84 billion in net income (profit) each year or $12.04 on an earnings per share basis. Anthem employs 56,000 workers across the globe.
How can I contact Anthem?
Anthem's mailing address is 120 MONUMENT CIRCLE, INDIANAPOLIS IN, 46204. The company can be reached via phone at 800-331-1476 or via email at [email protected]
MarketBeat Community Rating for Anthem (ANTM)
MarketBeat's community ratings are surveys of what our community members think about Anthem and other stocks. Vote "Outperform" if you believe ANTM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ANTM will underperform the S&P 500 over the long term. You may vote once every thirty days.
